Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Amezcua, Lilyana
CELLO, NCT04877457: Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.	Terminated	4	3	US	Ocrelizumab, Placebo	Yale University, Genentech, Inc.	Radiologically Isolated Syndrome, Multiple Sclerosis	06/23	06/23
OPTIS, NCT05566769: Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD	Recruiting	N/A	103	Europe, US	NMOSDCopilot smartphone application	Ad scientiam	Neuromyelitis Optica	04/25	04/26
William, Sylvia
CELLO, NCT04877457: Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.	Terminated	4	3	US	Ocrelizumab, Placebo	Yale University, Genentech, Inc.	Radiologically Isolated Syndrome, Multiple Sclerosis	06/23	06/23